Tuzulby
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Tuzulby, covering 2025-12-19 to 2026-08-14. Get the full timeline:
Most recent: EMA Authorised: Tuzulby (methylphenidate hydrochloride) — Neuraxpharm Pharmaceuticals S.L.